Authors:
Global | Publication | August 2024
Our regulation and investigations team has published the second article in their series on how companies will need to implement “reasonable procedures” to prevent fraud.
Read the full Inside Disputes blog, "Failure to prevent fraud: What to do now? Part 2: Policies and procedures."
In April 2024, the Republic of Türkiye has imposed sanctions on Israel, banning the export of 54 product groups (identified for potential military use) in response to Israel’s failure to comply with the binding decisions of the United Nations Security Council and the International Court of Justice. A month later, Türkiye announced that they extended the trade ban on Israel to an exportation and importation restriction covering all products.
While specific penalties for non-compliance have not been specified, it has been reported that in practice no products coming from Israel or destined for Israel are processed at Turkish customs. The penalties for and requirements arising from the non-compliance are expected to be announced shortly.
Publication
Africa faces a stark reality: contributing less than 4% of global greenhouse gas emissions, the continent is disproportionately impacted by climate change, threatening its development and stability.
Publication
Facing the fast-growing development of AI across the globe, particularly Generative AI (GenAI), the G7 competition authorities and policymakers (Canada, France, Germany, Japan, Italy, the UK and the US) and the European Commission met in Italy on 3-4 October 2024 to discuss the main competition challenges raised by these new technologies in digital markets.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023
